34007
羟基甲硝唑
VETRANAL®, analytical standard
别名:
1-(2-羟乙基)-2-羟甲基-5-硝基咪唑, MNZOH, 羟基甲硝唑
等级
analytical standard
质量水平
产品线
VETRANAL®
保质期
limited shelf life, expiry date on the label
技术
HPLC: suitable
gas chromatography (GC): suitable
应用
forensics and toxicology
pharmaceutical (small molecule)
包装形式
neat
SMILES字符串
OCCn1c(CO)ncc1[N+]([O-])=O
InChI
1S/C6H9N3O4/c10-2-1-8-5(4-11)7-3-6(8)9(12)13/h3,10-11H,1-2,4H2
InChI key
AEHPOYAOLCAMIU-UHFFFAOYSA-N
一般描述
羟基甲硝唑是一种基因毒性、致癌和致突变的硝基咪唑类药物，可作为广谱兽药治疗和预防农场动物的细菌和原虫感染疾病。
应用
有关合适仪器技术的更多信息，请参考产品′s分析证书。如需进一步支持，请联系技术服务。
羟基甲硝唑可作为标准品，通过超高效液相色谱 (UPLC) -四极杆/线性离子阱质谱法 (UPLC-Qtrap-MS/MS)和超高效液相色谱 -飞行时间质谱 (TOF) 法测定水样和肉类基质中的羟基甲硝唑抗生素。
其他说明
在我们的NMR在线平台ChemisTwin®上可以找到本品对应的数字化标准物质。您可使用ChemisTwin®上的数字等效品鉴定您的样品并进行定量分析（使用数字化外标）。可查看该物质的NMR谱图，只需点击几次鼠标，就能进行在线样品比对。欢迎点击了解更多，开启免费试用之旅。
法律信息
VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany
储存分类代码
11 - Combustible Solids
WGK
WGK 3
个人防护装备
Eyeshields, Gloves, type N95 (US)
C M Passmore et al.
British journal of clinical pharmacology, 26(1), 45-51 (1988-07-01)
1. Milk and plasma metronidazole and hydroxymetronidazole concentrations were measured in 12 breast-feeding patients following multiple doses of metronidazole (400 mg three times daily). All patients received metronidazole in combination with other broad spectrum antibiotics. 2. Plasma concentrations of both
Determination and confirmation of metronidazole, dimetridazole, ronidazole and their metabolites in bovine muscle by LC-MS/MS.
Granja MMHR, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment, 30(6), 970-976 (2013)
M J Jessa et al.
Journal of chromatography. B, Biomedical applications, 677(2), 374-379 (1996-03-03)
A rapid and selective HPLC method has been developed for the separation and quantitation of metronidazole and its hydroxylated metabolite in human plasma, saliva and gastric juice. The assay requires a simple protein precipitation step prior to analysis and is
S Loft et al.
Human & experimental toxicology, 9(3), 155-159 (1990-05-01)
1 The disposition of metronidazole and its major metabolites was compared in 11 subjects aged 86 +/- 6 years and 8 aged 30 +/- 6 years. 2 The plasma clearance of metronidazole was 1.20 +/- 0.53 and 1.25 +/- 0.22
P Hall et al.
Archives of disease in childhood, 58(7), 529-531 (1983-07-01)
Twenty four neonates at high risk of anaerobic sepsis were treated with intravenous metronidazole, 7.5 mg/kg, 8 hourly, for a mean period of 5 days. The highest observed concentration after the first dose (mean +/- SD) 9.6 +/- 4.0 mg/l
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持